Skip to main content
Two women talking, preparing to play tennis
Lilly Support Services logo

Access Savings and Support with Lilly Support Services™ for Taltz®

Lilly Support Services is a free program that provides savings and support to help you get started on Taltz. After enrolling, you receive ongoing assistance and services to help you get started and manage your condition along your treatment journey, including:

Hypothetical Patient

Lilly Support Services logo

Access Savings and Support with Lilly Support Services™ for Taltz®

Lilly Support Services is a free program that provides savings and support to help you get started on Taltz. After enrolling, you receive ongoing assistance and services to help you get started and manage your condition along your treatment journey, including:

taltz savings icon

Taltz Savings Card

For eligible and commercially insured patients.

No matter what your insurance covers, pay as little as $5* or $25† a month for Taltz

*If Taltz is covered by your insurance
†If Taltz is not covered by your insurance

Governmental beneficiaries excluded. Eligibility required, terms and conditions apply. Savings subject to monthly and annual limits. Month is defined as 28-days and up to 3 pens. Card eligibility and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. PROGRAM IS NOT INSURANCE. Review full terms and conditions below.

savings icon

Insurance Help

Lilly Support Services helps manage the insurance process with your doctor, specialty pharmacy, and your insurance company to get your medication delivered directly to your door.

training icon

Injection Training

Access resources like videos and over the phone training by a registered nurse to help you feel confident using our devices.

medication icon

Sharps Disposal

To safely dispose of your Taltz devices, Lilly Support Services participants can order and receive a free FDA-cleared sharps disposal container.

Enroll in Lilly Support Services

Enroll here

or call Lilly Support Services at 1-800-LillyRx

Zepbound® (tirzepatide) Savings for Taltz® Patients

Zepbound is an injectable prescription medicine that may help adults with obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off. Zepbound should be used with a reduced-calorie diet and increased physical activity. Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective for use in children.

See Safety Summary with Warnings below

Taltz® (ixekizumab) injection 80 mg/mL logo

A prescription medicine used to treat adults with active psoriatic arthritis (PsA) and is also used to treat adults and children six years and older with moderate to severe plaque psoriasis (PsO) who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light).

If you are taking Taltz and are also prescribed Zepbound, you may also be eligible for savings on Zepbound single dose pen

Governmental beneficiaries excluded, terms and conditions apply.

SELECT IMPORTANT SAFETY INFORMATION
Warning:
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Zepbound and medicines that work like Zepbound caused thyroid tumors, including thyroid cancer. It is not known if Zepbound will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Zepbound if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

TODO

You could pay as little as $25* per month for the Zepbound single-dose pen if you are:

TODO

Eligible and Commercially Insured

TODO

Covered for Taltz

Unsure? Call your insurance provider!

TODO

Taking Taltz and Also Prescribed Zepbound Single-Dose Pen

YOU DON’T NEED TO BE COVERED FOR ZEPBOUND TO QUALIFY!

*Governmental beneficiaries excluded. Eligibility required, terms and conditions apply. Savings subject to monthly and annual limits. Month is defined as 28-days and up to 4 single-dose pens. Card eligibility and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. PROGRAM IS NOT INSURANCE.

Review full terms and conditions below.

Ready to enroll?

You must be eligible and commercially insured when you enroll. Before beginning, please review the full terms & conditions and confirm your eligibility.

Enroll here

or call Lilly Support Services at 1-800-LillyRx

TODO

Helpful Resources

Still not sure if you’re eligible?

Check if you might be eligible for Zepbound Savings for Taltz Patients

Use this tool

Questions on enrolling?

Call Lilly Support Services, who can also help with your Taltz Savings Card or filling your Taltz prescription

Call 1-800-LILLYRX

Questions on filling your Zepbound prescription?

Call 1-833-366-7157

You can also give this resource to your pharmacist

Download resource

Terms and Conditions
By enrolling in the Zepbound Savings for Taltz Patients Savings Card Program ("Program") and using the Zepbound Savings for Taltz Patients Savings Card ("Card"), you attest that you meet the eligibility criteria, and you agree to comply with the terms and conditions described below:

Card Eligibility:

(1.) You have been prescribed Zepbound® (tirzepatide) single-dose pen for an approved use consistent with FDA approved product labeling;
(2.) You have been prescribed Taltz® (ixekizumab) for an approved use consistent with FDA approved product labeling;
(3.) You have commercial drug insurance that covers Taltz;
(4.) You have filled your Taltz prescription within the preceding (a) 45 days of filling your Zepbound prescription if you were prescribed a 28 day supply of Taltz, (b) 90 days of filling your Zepbound prescription if you were prescribed a 56 day supply of Taltz, or (c) 110 days if you were prescribed an 84 day supply of Taltz ("Taltz Fill Timeframe");
(5.) You are enrolled in the Taltz Savings Card Program;
(6.) You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state prescription drug assistance program;
(7.) You are a resident of the United States or Puerto Rico; and
(8.) You are 18 years of age or older.

Card Terms and Conditions

For patients with commercial drug insurance coverage for Zepbound: In order to be eligible to pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill of Zepbound single dose pen, you must: (a) have commercial drug insurance that covers Zepbound and a prescription for Zepbound single-dose pen consistent with FDA-approved product labeling; (b) have commercial drug insurance that covers Taltz and a prescription consistent with FDA-approved product labeling; (c) be enrolled in the Taltz Savings Card Program; and (d) have filled your Taltz prescription within the Taltz Fill Timeframe. Verification of a Taltz fill within the Taltz Fill Timeframe is not required for your first Zepbound prescription fill but is required for all subsequent Zepbound prescription fills. Month is defined as 28-days and up to 4 single-dose pens. Card savings are subject to a maximum monthly savings of up to $295 per 1-month prescription, $590 per 2-month prescription, or $885 per 3-month prescription fill and a separate maximum annual savings of up to $3,835 per calendar year. Card may be used for a maximum of up to 13 prescription fills per calendar year. Participation in the Program requires a valid patient HIPAA authorization. If you discontinue filling your Taltz prescription for any reason, you may use this Card on or before 12/31/2026 for a maximum of one additional prescription fill, to pay as little as $25 for a 1-month, 2-month, or 3-month supply of Zepbound single-dose pen. After you have utilized this one additional prescription fill of Zepbound single-dose pen following discontinuation of Taltz, you will no longer be eligible to use this Card. Subject to Lilly USA, LLC's ("Lilly") right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly's sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2026.

For patients with commercial drug insurance who do not have coverage for Zepbound: In order to be eligible to pay as little as $25 for a 1-month prescription fill of Zepbound single dose pen, you must: (a) have commercial drug insurance that does not cover Zepbound and a prescription for Zepbound single-dose pen consistent with FDA-approved product labeling; (b) have commercial drug insurance that covers Taltz and a prescription consistent with FDA-approved product labeling; (c) be enrolled in the Taltz Savings Card Program; and (d) have filled your Taltz prescription within the Taltz Fill Timeframe. Verification of a Taltz fill within the Taltz Fill Timeframe is not required for your first Zepbound prescription fill but is required for all subsequent Zepbound prescription fills. Month is defined as 28-days and up to 4 single-dose pens. Card savings are subject to a maximum monthly savings of $1,094 for one 28-day supply of Zepbound and a separate maximum annual savings of $14,221 per calendar year. Card may be used for a maximum of up to 13 prescription fills per calendar year. Participation in the Program requires a valid patient HIPAA authorization. If you discontinue filling your Taltz prescription for any reason, you may use this Card on or before 12/31/2026 for a maximum of one additional prescription fill, to pay as little as $25 for a 1-month supply of Zepbound single-dose pen. After you have utilized this one additional prescription fill of Zepbound following discontinuation of Taltz, you will no longer be eligible to use this Card. Subject to Lilly's right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly's sole discretion, without notice, and for any reason, Card expires and savings end on 12/31/2026.

Post-Transaction Reimbursement

Savings may not be applied at the point of sale and may require further action from you to obtain the applicable savings. If you filled your Taltz prescription within the Taltz Fill Timeframe and otherwise meet the Card Eligibility and Zepbound Savings for Taltz Patients - Additional Requirements outlined above, but Lilly was not able to verify such at the point of sale, you may submit a claim for Post Transaction Reimbursement. A Post-Transaction Reimbursement claim may result in Lilly issuing you a reimbursement for the difference between what you paid and what you would have paid had Lilly been able to verify at the point of sale that your Taltz prescription had been filled within the Taltz Fill Timeframe. Claims for Post-Transaction Reimbursement must be submitted through the Program's online patient reimbursement portal https://eversana-ptr.virtualrx.co or by mailing a completed claim form to Savings Card Post-Transaction Reimbursement, PO BOX 42638 Cincinnati, OH 45242 Attn: PTR Processing. For a copy of the claim form, please call 1-866-923-1953. A valid Post-Transaction Reimbursement claim must include: your name; date of birth; address; a copy of your primary insurance card; a copy of your original activated Zepbound Savings for Taltz Patients Savings Card information; original pharmacy receipt for your Zepbound single-dose pen prescription; a cash register receipt or Explanation of Benefit (EOB) for your Zepbound single-dose pen prescription; original pharmacy receipt for your Taltz prescription; and a cash register receipt or Explanation of Benefit (EOB) for your Taltz prescription. At its sole discretion, Lilly may request additional information to validate your claim for reimbursement and is not obligated or required to reimburse any amounts if the requested additional information is not provided. Claims for reimbursement must be submitted in the patient portal or postmarked by no later than March 31, 2027. Reimbursement claims are subject to program eligibility and terms and conditions, including Lilly's right to terminate, rescind, revoke, or amend the post-transaction reimbursement program at any time in Lilly's sole discretion, without notice, and for any reason.

Additional Terms and Conditions
If you have an insurance plan that is participating in an alternate funding program ("AFP") that requires you to apply to the Zepbound Savings for Taltz Patients Savings Card Program or otherwise pursue specialty drug prescription coverage through an alternate funding vendor as a condition of, requirement for, or prerequisite to coverage of Zepbound, you are not eligible for and are prohibited from using the Zepbound Savings for Taltz Patients Savings Card Program. AFPs include programs where coverage, reimbursement, or patient out of pocket costs for a product in some way vary based on the availability of a manufacturer co-pay program. AFPs may modify, delay, deny, restrict, or withhold insurance benefits or coverage from patients, or exclude Lilly products from coverage contingent upon a member's use of the Zepbound Savings for Taltz Patients Savings Card Program. You agree to inform the Zepbound Savings for Taltz Patients Savings Card Program if you are or become a member of such an alternative funding program. You are responsible for any applicable taxes, fees, and any amount that exceeds the applicable monthly or annual maximum Card savings. Monthly and annual maximum savings are set at Lilly's sole and absolute discretion and may be changed with or without notice at any time for any reason. At its sole discretion and with or without notice, Lilly may reduce, eliminate, or otherwise modify the Card savings for any reason, including but not limited to if your commercial drug insurance plan imposes additional requirements which limits or prevents you from receiving coverage for Zepbound, only allows partial coverage for Zepbound, removes coverage for Zepbound and requires you to utilize the Card, does not provide a material level of financial assistance for the cost of Zepbound, or does not apply Card payments to satisfy your co- payment, deductible, or coinsurance for Zepbound. Card savings are available only for Zepbound prescriptions for the single-dose pen (NDC 00002-2506-80, NDC 00002-2495-80, NDC 00002-2484-80, NDC 00002-2471-80, NDC 00002-2460-80, NDC 00002-2457-80). Other methods of administration are not eligible for Program savings. Card savings are not valid for: Massachusetts residents if an AB-rated generic equivalent is available; California residents if an FDA-approved therapeutic equivalent is available. You must meet the Card eligibility criteria, terms and conditions every time you use the Card. Card activation is required. You may not seek reimbursement from your health insurance, any third party, or any health savings, flexible spending, or other healthcare reimbursement accounts, for any amount of the savings received through the Card. By utilizing the Card, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you will notify your Insurance Carrier of your redemption of the Card. Card savings cannot be combined or utilized with any other program, discount, discount card, cash discount card, coupon, incentive, or similar offer involving Zepbound. You agree that this Card savings is intended solely for the benefit of you, the patient, and that the Card benefits are non-transferable. It is prohibited for any person to sell, purchase, or trade; or to offer to sell, purchase, or trade, or to counterfeit the Card. THIS CARD IS NOT INSURANCE. Lilly has the sole right to interpret and apply Card eligibility criteria, and terms and conditions. Card eligibility, and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. Lilly's sole discretion to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions includes the right to terminate any individual Card if Lilly determines, in its sole discretion, that a patient does not satisfy the Card's eligibility criteria or is using or has attempted to use the Card inconsistently with these terms and conditions. Eligibility criteria, and terms and conditions for the Zepbound Savings for Taltz Patients Savings Card Program may change from time to time; the most current version can be found at https://www.taltz.lilly.com/savings-support#zepbound-savings-for-taltz-patients . You may be required to obtain a new Card, including if any Card terms and conditions have been terminated, rescinded, revoked, or amended by Lilly. Card void where prohibited by law. Subject to Lilly's right to terminate, rescind, revoke or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly's sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2026.

call Taltz icon

Have concerns about paying for Taltz?

We're here to help. Contact Lilly Support Services at 1-800-LillyRx (1-800-545-5979) for more information.

Call Lilly Support Services
Man smiling into camera

Getting the care you need can be quick and accessible

Avoid the wait times to connect with a dermatologist. Access focused care with independent telehealth or in-person providers through LillyDirect®.

Find care

LillyDirect® is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
PP-LX-US-0344 06/2025 ©LLilly USA, LLC 2025. All rights reserved..

LillyDirect® is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
PP-LX-US-0344 06/2025 ©Lilly USA, LLC 2025. All rights reserved..

Taltz Savings Card Program Terms and Conditions

By enrolling in the Taltz Savings Card Program (“Program”) and using the Taltz Savings Card (“Card”), you attest that you meet the eligibility criteria, agree to, and will comply with the terms and conditions described below:

Card Eligibility:

  1. You have been prescribed Taltz® (ixekizumab) for an approved use consistent with FDA approved product labeling;
  2. You are enrolled in a commercial drug insurance plan;
  3. You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state prescription drug assistance program;
  4. You are a resident of the United States or Puerto Rico; and
  5. You are 18 years of age or older.

Card Terms and Conditions:

For patients with commercial drug insurance coverage for Taltz: You must have commercial drug insurance that covers Taltz and a prescription for an approved use consistent with FDA-approved product labeling to pay as little as $5 for a 1-month prescription fill of Taltz. Month is defined as 28-days and up to 3 pens. Card must be first used by no later than 12/31/2026. Card savings are subject to a maximum monthly savings of wholesale acquisition cost plus usual and customary pharmacy charges and a separate maximum annual savings of up to $10,600 per calendar year. Card may be used for a maximum of up to 14 prescription fills per calendar year, subject to the previously stated maximum monthly and annual savings limit. Except where prohibited by applicable state law, Card monthly and annual savings are reduced if Lilly identifies that you are enrolled in a plan or program, sometimes called a maximizer plan, that adjusts your cost sharing amount to be equal to or include some portion of the savings provided by the Card and attempts to prevent the savings from this Card from being applied to your out-of-pocket costs, including but not limited to copayments, coinsurances, and deductibles (“Maximizer”). If the Program identifies you are enrolled in a Maximizer, Card savings are reduced to a maximum monthly savings of up to $25 and a separate maximum annual savings of up to $350 per calendar year. If you have reason to believe that the Program erroneously identified enrollment in a Maximizer, please call the Taltz Savings Card Program at 1-800-LillyRx (1-800-545-5979). Participation in the Program requires a valid patient HIPAA authorization upon enrollment into the Program. Subject to Lilly USA, LLC’s right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2028 or 24 months after you first use the Card, whichever comes first.

For patients with commercial drug insurance who do not have coverage for Taltz: You must have commercial drug insurance that does not cover Taltz and a prescription for an approved use consistent with FDA-approved product labeling to pay as little as $25 for a 1-month supply of Taltz. Month is defined as 28-days and up to 3 pens. Card savings are subject to a maximum monthly savings of wholesale acquisition cost plus usual and customary pharmacy charges, up to a maximum of up to 14 prescription fills per calendar year. Card must be first used by no later than 12/31/2026. Participation in the Program requires submission of a prior authorization (PA) prior to the first prescription fill. If coverage is denied, an appeal must be submitted prior to 5th month prescription fill. To remain eligible for the Program, a new PA, appeal, or medical exception must be submitted prior to the 13th prescription fill and as required by Lilly at its sole discretion. Participation in the Program requires a valid patient HIPAA authorization to remain in the Program. Subject to Lilly USA, LLC’s right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions, which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2028 or 24 months after you first use the Card, whichever comes first.

Additional Program Terms and Conditions

If you have an insurance plan that is participating in an alternate funding program (“AFP”) that requires you to apply to the Taltz Savings Card Program or otherwise pursue specialty drug prescription coverage through an alternate funding vendor as a condition of, requirement for, or prerequisite to coverage of Taltz, you are not eligible for and are prohibited from using the Taltz Savings Card Program. AFPs include programs where coverage, reimbursement, or patient out of pocket costs for a product in some way vary based on the availability of a manufacturer co-pay program. AFPs may modify, delay, deny, restrict, or withhold insurance benefits or coverage from patients, or exclude Lilly products from coverage contingent upon a member’s use of Taltz Savings Card Program. You agree to inform Taltz Savings Card Program if you are or become a member of such an alternative funding program. You are responsible for any applicable taxes, fees, and any amount that exceeds the applicable monthly or annual maximum Card savings. Monthly and annual maximum savings are set at Lilly’s sole and absolute discretion and may be changed with or without notice at any time for any reason. At its sole discretion and with or without notice, Lilly may reduce, eliminate, or otherwise modify the Card savings for any reason, including but not limited to if your commercial drug insurance plan imposes additional requirements which limits or prevents you from receiving coverage for Taltz, only allows partial coverage for Taltz, removes coverage for Taltz and requires you to utilize the Card, does not provide a material level of financial assistance for the cost of Taltz, or does not apply Card payments to satisfy your co-payment, deductible, or coinsurance for Taltz. Card savings are not valid for: Massachusetts residents if an AB-rated generic equivalent is available; California residents if an FDA-approved therapeutic equivalent is available. You must meet the Card eligibility criteria, terms and conditions every time you use the Card. If at any time you begin receiving drug coverage under any state, federal, or government funded healthcare program, you understand that you will no longer be eligible for the Taltz Savings Card and agree to call the Taltz Savings Card Program at 1-800-LillyRx (1-800-545-5979) to stop participation. Card activation is required. You may not seek reimbursement from your health insurance, any third party, or any health savings, flexible spending, or other healthcare reimbursement accounts, for any amount of the savings received through the Card. By utilizing the Card, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you will notify your Insurance Carrier of your redemption of the Card. Card savings cannot be combined or utilized with any other program, discount, discount card, cash discount card, coupon, incentive, or similar offer involving Taltz. You agree that this Card savings is intended solely for the benefit of you, the patient, and that the Card benefits are non-transferable. It is prohibited for any person to sell, purchase, or trade; or to offer to sell, purchase, or trade, or to counterfeit the Card. THIS CARD IS NOT INSURANCE. Lilly has the sole right to interpret and apply Card eligibility criteria, and terms and conditions. Card eligibility, and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. Lilly’s sole discretion to terminate, rescind, revoke, or amend Card eligibility and/or Card terms and conditions includes the right to terminate any individual Card if Lilly determines, in its sole discretion, that a patient does not satisfy the Card’s eligibility criteria or is using or has attempted to use the Card inconsistently with these terms and conditions. Eligibility criteria, and terms and conditions for the Taltz Savings Card Program may change from time to time; the most current version can be found at https://www.taltz.lilly.com/savings-support. You may be required to obtain a new Card, including if any Card terms and conditions have been terminated, rescinded, revoked, or amended by Lilly. Card void where prohibited by law. Subject to Lilly’s right to terminate, rescind, revoke or amend Card eligibility criteria and/or Card terms and conditions, which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2028 or 24 months after you first use the Card, whichever comes first.

TRICARE® is a registered trademark of the Department of Defense (DoD), DHA.

INDICATIONS AND SAFETY SUMMARY FOR TALTZ

Advertencia:

Taltz® (tȯl-ts) is an injectable medicine used to treat:

  • People 6 years of age and older with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
  • Adults with active psoriatic arthritis.
  • Adults with active ankylosing spondylitis.
  • Adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.

It is not known if Taltz is safe and effective in children for conditions other than plaque psoriasis or in children under 6 years of age.

Warnings - Taltz affects the immune system. It may increase your risk of infections, some people have had serious infections, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have been hospitalized from these infections. Do not use Taltz if you have any symptoms of infection, unless your doctor tells you to. If you have a symptom after starting Taltz, call your doctor right away.

Your doctor should check you for TB before you start Taltz, and watch you closely for signs of TB during and after treatment with Taltz. If you have TB, or had it in the past, your doctor may treat you for it before you start Taltz.

Do not use Taltz if you have had a serious allergic reaction to ixekizumab or any other ingredient in Taltz, such as: swelling of your eyelids, lips, mouth, tongue or throat, trouble breathing, feeling faint, throat or chest tightness, or skin rash. Get emergency help right away if you have any of these reactions. See the Medication Guide that comes with Taltz for a list of ingredients.

Severe skin reactions that look like eczema can happen during treatment with Taltz from days to months after your first dose and can sometimes lead to hospitalization. Your doctor may temporarily stop treatment with Taltz if you develop severe skin reactions. Tell your doctor if you have any of the following: redness or rash, itching, patches, your skin is dry or feels like leather, blisters or abrasions that ooze or become crusty, small bumps or plaques with scale or crusting.

Crohn’s disease or ulcerative colitis (inflammatory bowel disease) can start or get worse with Taltz use. Tell your doctor if you have any of these symptoms or if they get worse: stomach pain, diarrhea, and weight loss.

You should not get live vaccines while taking Taltz. You should get the vaccines you need before you start Taltz.

Common side effects
The most common side effects of Taltz include:

  • Injection site reactions
  • Nausea
  • Upper respiratory infections
  • Fungal skin infections

Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before using

Before you use Taltz, review these questions with your doctor:

❑ Are you being treated for an infection?
❑ Do you have an infection that does not go away or keeps coming back?
❑ Do you have TB or have you been in close contact with someone with TB?
❑ Do you have possible symptoms of an infection such as fever, cough, sores, diarrhea, or other symptoms? Ask your doctor about other possible symptoms.
❑ Do you have Crohn’s disease or ulcerative colitis?

Tell your doctor if:

❑ You need any vaccines or have had one recently.
❑ You take prescription or over-the-counter medicines, vitamins, or herbal supplements.
❑ You are pregnant or planning to become pregnant. It is not known if Taltz can harm an unborn baby. Pregnancy Exposure Registry: There is a pregnancy registry to collect information about women who are exposed to Taltz during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. If you become pregnant while taking Taltz, you are encouraged to enroll in the pregnancy registry by calling 1-800-284-1695 or by visiting online at http://www.pregnancyregistry.lilly.com .
❑ You are breastfeeding or planning to breastfeed. It is not known if Taltz passes into breastmilk.

How to take

See the instructions for use that come with Taltz. There you will find information about how to store, prepare, and inject Taltz. Adults may self-inject after receiving training from a healthcare provider.

For children 6 to 17 years of age:

  • If your child’s healthcare provider decides that you may give Taltz injections at home, you should receive training on the right way to prepare and inject Taltz. Do not try to give Taltz to your child until you have been shown how to inject Taltz. Children should not inject themselves with Taltz. You or an adult caregiver should prepare and give Taltz injections to your child.

Learn more

Taltz is a prescription medicine available as a 80 mg/mL, 40 mg/0.5mL, 20 mg/0.25mL injection. For more information, call 1-800-545-5979 or go to taltz.lilly.com .

This summary provides basic information about Taltz but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other healthcare provider about Taltz and how to take it. Your doctor is the best person to help you decide if Taltz is right for you.

IX CON BS 20AUG2024

Taltz® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Taltz® (tȯl-ts) is an injectable medicine used to treat:

  • People 6 years of age and older with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
  • Adults with active psoriatic arthritis.
  • Adults with active ankylosing spondylitis.
  • Adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.

It is not known if Taltz is safe and effective in children for conditions other than plaque psoriasis or in children under 6 years of age.

INDICATIONS AND SAFETY SUMMARY WITH WARNINGS FOR ZEPBOUND

Indications

Zepbound® (ZEHP-bownd) is an injectable prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with:

  • obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off.
  • moderate-to-severe obstructive sleep apnea (OSA) and obesity to improve their OSA.

Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective for use in children.

Warnings - Zepbound may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.

  • Do not use Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
  • Do not use Zepbound if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use Zepbound if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Zepbound.

KwikPen®: Do not share your KwikPen with other people, even if the pen needle has been changed.

You may give other people a serious infection or get a serious infection from them.

Zepbound may cause serious side effects, including:

Severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Zepbound. Tell your healthcare provider if you have stomach problems that are severe or will not go away.

Dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.

Gallbladder problems. Gallbladder problems have happened in some people who use Zepbound. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), or clay-colored stools.

Inflammation of the pancreas (pancreatitis). Stop using Zepbound and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. You may feel the pain from your abdomen to your back.

Serious allergic reactions. Stop using Zepbound and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, or very rapid heartbeat.

Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Zepbound with medicines that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness or feeling jittery.

Changes in vision in patients with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Zepbound.

Food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Zepbound may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Zepbound before you are scheduled to have surgery or other procedures.

Common side effects
The most common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn. These are not all the possible side effects of Zepbound. Talk to your healthcare provider about any side effect that bothers you or doesn't go away.

Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before using Zepbound

  • Your healthcare provider should show you how to use Zepbound before you use it for the first time.
  • Talk to your healthcare provider about low blood sugar and how to manage it. Tell your healthcare provider if you are taking medicines to treat diabetes including an insulin or sulfonylurea.
  • If you take birth control pills by mouth, talk to your healthcare provider before you use Zepbound. Birth control pills may not work as well while using Zepbound. Your healthcare provider may recommend another type of birth control for 4 weeks after you start Zepbound and for 4 weeks after each increase in your dose of Zepbound.

Review these questions with your healthcare provider:

  • Do you have other medical conditions, including problems with your pancreas, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
  • Do you take diabetes medicines, such as insulin or sulfonylureas?
  • Do you have a history of diabetic retinopathy?
  • Are you scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)?
  • Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
  • Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? Zepbound may harm your unborn baby. Tell your healthcare provider if you become pregnant while using Zepbound. Zepbound may pass into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using Zepbound.
  • Pregnancy Exposure Registry: There will be a pregnancy exposure registry for women who have taken Zepbound during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry, or you may contact Lilly at 1-800-LillyRx (1-800-545-5979).

How to take

  • Read the Instructions for Use that come with Zepbound.
  • Use Zepbound exactly as your healthcare provider says.
  • Use Zepbound with a reduced-calorie diet and increased physical activity.
  • Inject Zepbound under the skin (subcutaneously) of your stomach (abdomen), thigh, or have another person inject in the back of the upper arm. Do not inject ZEPBOUND into a muscle (intramuscularly) or vein (intravenously).
  • Use Zepbound 1 time each week, at any time of the day.
  • Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.

If you take too much Zepbound, call your healthcare provider, call the Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.

Zepbound is approved as a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg injection.

Learn more

Zepbound is a prescription medicine. For more information, call 1-800-LillyRx (1-800-545-5979).

This summary provides basic information about Zepbound but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Zepbound and how to take it. Your healthcare provider is the best person to help you decide if Zepbound is right for you.

ZP CON BS 25FEB2026

Zepbound®, its delivery device base and KwikPen® are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.